Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: November 2013

HINJ Member Companies’ Economic Impact Exceeds $26 Billion in 2012, Finds New Study Conducted in Association with Deloitte

New Brunswick, NJ, November 13, 2013 ― Key findings from the HealthCare Institute of New Jersey’s (HINJ) 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.”

According to the study, which was conducted by Deloitte for the ninth consecutive year, participating HINJ member companies had a total impact on New Jersey’s economy of $26.6* billion in calendar year 2012, a healthy increase of 9.9 percent from 2010.

“HINJ member companies continue to be a major force in New Jersey’s economy in their pursuit of advancing global health,” said Dean J. Paranicas, President and Chief Executive Officer of HINJ.  “Our enduring goal is for patients everywhere to have access to the medicines, therapies and medical technologies they critically need.” Continue reading

Dr. Chris Molloy Assumes Role as Rutgers SVP for Research and Economic Development

New Brunswick, NJ, November 6, 2013 — On November 1, Christopher J. Molloy, Ph.D., who led the Rutgers-UMDNJ integration, assumed his new role the Rutgers’ senior vice president for research and economic development.

Dr. Molloy’s responsibilities include oversight and strategic planning for the university’s $700 million in annual research expenditures and management of the many institutional offices and resources that support Rutgers’ research and economic development activities. Continue reading

Registration Open for NJLSVA’s Annual Procurement Conference on November 13

Registration Is Now Open!

NEW JERSEY LIFE SCIENCES
VENDORS ALLIANCE’S (NJLSVA)
ANNUAL PROCUREMENT CONFERENCE

Wednesday, November 13, 2013
8:00 a.m. – Registration & Networking
8:45 a.m. to 12:00 p.m. – Program

Pfizer Inc.
100 Route 206 North
Peapack, NJ 

Learn About:

  • The Latest Trends in Pharmaceutical Industry Outsourcing
  • Issues in Washington and Trenton that Impact the Life Sciences Industry
  • Resources and Programs Offered by the State of New Jersey to Grow Your Business

To register, click here.

Free Admission.  Space is Limited. 
Pre-Registration is Required

For more information please call 732-729-9619

Rutgers’ Chancellor of Biomedical and Health Sciences to Start December 2

New Brunswick, NJ, November 4, 2013 — Brian L. Strom, M.D., M.P.H. — a renowned epidemiologist, award-winning teacher and clinician, and longtime academic leader at the University of Pennsylvania — will assume his new position as the inaugural chancellor of Rutgers Biomedical and Health Sciences (RBHS) on December 2.

Dr. Christopher J. Molloy, the interim chancellor, will become Rutgers University’s senior vice president for research and economic development once Dr. Strom becomes chancellor. Continue reading